[go: up one dir, main page]

ATE425741T1 - Arzneizubereitung und deren anwendung zur behandlung von erkrankungen des inneren ohres - Google Patents

Arzneizubereitung und deren anwendung zur behandlung von erkrankungen des inneren ohres

Info

Publication number
ATE425741T1
ATE425741T1 AT03766101T AT03766101T ATE425741T1 AT E425741 T1 ATE425741 T1 AT E425741T1 AT 03766101 T AT03766101 T AT 03766101T AT 03766101 T AT03766101 T AT 03766101T AT E425741 T1 ATE425741 T1 AT E425741T1
Authority
AT
Austria
Prior art keywords
compound
diseases
treatment
inner ear
medicinal preparation
Prior art date
Application number
AT03766101T
Other languages
English (en)
Inventor
Werner Bieberschulte
Klaus Ehrenberger
Original Assignee
Phafag Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phafag Ag filed Critical Phafag Ag
Application granted granted Critical
Publication of ATE425741T1 publication Critical patent/ATE425741T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0046—Ear
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT03766101T 2002-07-31 2003-07-30 Arzneizubereitung und deren anwendung zur behandlung von erkrankungen des inneren ohres ATE425741T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH13572002 2002-07-31

Publications (1)

Publication Number Publication Date
ATE425741T1 true ATE425741T1 (de) 2009-04-15

Family

ID=31193661

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03766101T ATE425741T1 (de) 2002-07-31 2003-07-30 Arzneizubereitung und deren anwendung zur behandlung von erkrankungen des inneren ohres

Country Status (11)

Country Link
US (1) US20050288292A1 (de)
EP (1) EP1530455B1 (de)
KR (1) KR20050042140A (de)
CN (1) CN100479818C (de)
AT (1) ATE425741T1 (de)
AU (1) AU2003250707A1 (de)
CA (1) CA2493289C (de)
DE (1) DE60326731D1 (de)
ES (1) ES2325209T3 (de)
HK (1) HK1083197A1 (de)
WO (1) WO2004012705A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8275615B2 (en) * 2007-07-13 2012-09-25 International Business Machines Corporation Model weighting, selection and hypotheses combination for automatic speech recognition and machine translation
WO2017210553A1 (en) 2016-06-03 2017-12-07 Hough Ear Institute Combination therapies for inner ear sensory hair cell regeneration/replacement
KR102630617B1 (ko) * 2016-06-24 2024-01-29 (주) 에이치엔에이파마켐 페오포르비드 a 및 폴리에틸렌글리콜의 지질 유도체의 결합체를 함유하는 항균 리포좀 조성물
KR102019589B1 (ko) * 2018-01-23 2019-11-04 가톨릭대학교 산학협력단 내이에서의 약물전달용 나노입자

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0032564A1 (de) * 1979-12-28 1981-07-29 Medichemie Ag Pharmazeutische Verwendung von Caroverin und/oder Caroverinsalzen sowie Caroverinsalze mit Xanthinderivat-Säureresten und Nicotinsäurerest
JPS5857317A (ja) * 1981-10-02 1983-04-05 Mitsubishi Chem Ind Ltd 抗ガン作用増強剤
US5446070A (en) * 1991-02-27 1995-08-29 Nover Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
NZ238867A (en) * 1990-07-12 1993-08-26 Alza Corp Dosage form for delayed release comprising pharmaceutically active substance and a drug-release hindering means and a second composition which imbibes fluid, expands, and ejects the active substance from the device
US5156850A (en) * 1990-08-31 1992-10-20 Alza Corporation Dosage form for time-varying patterns of drug delivery
EP0542689B1 (de) * 1991-11-15 1998-09-23 Phafag Aktiengesellschaft Verwendung von 1-(aminoalkyl)-3-Quinoxalin-2-on Derivaten zur Herstellung von neuroprotektiven Mitteln
ES2123546T3 (es) * 1991-11-15 1999-01-16 Phafag Ag Uso de derivados de 1-(aminoalquil)-3-quinoxalina-2-ona para la preparacion de composiciones neuroprotectoras.
AT408837B (de) * 1998-06-19 2002-03-25 Phafag Ag Verwendung von caroverin und/oder caroverin. hydrochlorid zur herstellung von als antioxidantien wirkenden zusammensetzungen und/oder von neuroregenerativen zusammensetzungen
US6093417A (en) * 1999-01-11 2000-07-25 Advanced Medical Instruments Composition to treat ear disorders

Also Published As

Publication number Publication date
US20050288292A1 (en) 2005-12-29
AU2003250707A1 (en) 2004-02-23
CN100479818C (zh) 2009-04-22
WO2004012705A1 (en) 2004-02-12
KR20050042140A (ko) 2005-05-04
EP1530455B1 (de) 2009-03-18
EP1530455A1 (de) 2005-05-18
DE60326731D1 (de) 2009-04-30
CA2493289C (en) 2014-12-16
CN1671360A (zh) 2005-09-21
HK1083197A1 (en) 2006-06-30
CA2493289A1 (en) 2004-02-12
ES2325209T3 (es) 2009-08-28

Similar Documents

Publication Publication Date Title
TW200621762A (en) Novel compounds
ATE407928T1 (de) Amino-phtalazinon derivate, anwendung als kinase inhibitoren, herstellung und pharmazeutische zusammensetzung
NO20042596L (no) Inbibitorer av 11-beta-hydroksy steroid dehydrogenase type 1
TR200302242T2 (tr) Protein kinaz önleyicileri olarak pirolopirimidinler
BR0208678A (pt) Composto, composição farmacêutica, uso de um composto
BR0113838A (pt) Derivados de n-fenil-2-pirimidina-amina
UY27592A1 (es) Nuevo uso
SE0104341D0 (sv) New use
BRPI0416801A (pt) derivados de 1h-imidazoquinolina como inibidores de proteìna sinase
SE0001899D0 (sv) New compounds
GEP20053600B (en) 3-(4-Amidopyrrol-2-Ylmethlidene)-2- Indolinone Derivatives as Protein Kinase Inhibitors
MA27093A1 (fr) Derives de sulfonamides, leur preparation et leur application comme medicaments.
HUP0401638A2 (hu) Daganatellenes hatású tiofén- és tiazolszulfonamid származékok, valamint ezeket tartalmazó gyógyászati készítmények
GB0112348D0 (en) Compounds
UA85708C2 (ru) Лекарственные комбинации, содержащие бензоксазины, для лечения заболеваний дыхательных путей
NO20050851L (no) Kaspase-inhibitorer og anvendelser derav
TNSN04034A1 (en) Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof
ATE233754T1 (de) Diphenyl-piperidin derivate
WO2006125194A3 (en) Piperazine derivatives and their uses as therapeutic agents
NO20050569L (no) Fremgangsmate for behandling av alvorlig hjertesvikt og medikament for dette
NO20072089L (no) Benzimidazolderivater, sammensetninger som inneholder dem, fremstilling derav og anvendelse derav
HK1083197A1 (en) A pharmaceutical formulation and its use in the treatment of inner ear diseases
TW200420567A (en) Quinazoline derivatives
PE20030236A1 (es) Derivados de bencimidazol 1-aril-2-n,s- u o-sustituidos, obtencion de medicamentos y preparados farmaceuticos que contienen estos derivados
MY139613A (en) Novel piperazinyl-pyrazinone derivatives for the treatment of 5-ht2a receptor-related disorders

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1530455

Country of ref document: EP